Autopsy report · NCT02702492
PAK4 and NAMPT in Patients With Solid Malignancies or NHL (PANAMA)
Cause of deathFunding or business
“sponsor decision”
Life of this trial
- Registered 3 months before it started.
- Ran for about 4 years 8 months before it stopped.
- 60 participants enrolled.
- Results were posted on the registry 3 years 10 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1
- Sponsor
- Karyopharm Therapeutics Inc
- Sponsor type
- Industry
- Conditions
- Solid Tumors; NHL
- Interventions
- KPT-9274; Niacin ER; Nivolumab
- Participants
- 60
- Sites
- 8
- Countries
- Canada, United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.